+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vitro Lung Model Market by Model Type, Application, Cell Source, Technology, Product Type, End Users - Global Forecast to 2030- Product Image
In Vitro Lung Model Market by Model Type, Application, Cell Source, Technology, Product Type, End Users - Global Forecast to 2030- Product Image
Sale

In Vitro Lung Model Market by Model Type, Application, Cell Source, Technology, Product Type, End Users - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889471
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in vitro lung model market is rapidly redefining respiratory research, providing decision-makers in pharma, biotech, and academia with vital platforms for disease modeling, drug discovery, and toxicity testing. As technology evolves and regulatory landscapes shift, these advanced models allow for more predictive and human-relevant data integration across diverse R&D workflows.

Market Snapshot: In Vitro Lung Model Market Trends

Valued at USD 689.38 million in 2024 and projected to reach USD 812.58 million in 2025, the in vitro lung model market demonstrates robust year-on-year expansion. Continued growth at a CAGR of 17.05% is forecast to drive revenues to USD 1.77 billion by 2030. This reflects strong demand from pharmaceutical, biotechnology, academic, and contract research sectors seeking alternatives to animal testing and aiming to accelerate respiratory drug development with higher-fidelity, scalable platforms.

Scope & Segmentation Overview

  • Model Types: Includes 2D cell cultures, cell line cultures, primary cell cultures, 3D alveolar organoids, bronchial organoids, lung-on-a-chip platforms, and precision-cut lung slices.
  • Applications: Disease modeling, drug discovery and development, personalized medicine, as well as toxicity testing protocols.
  • Cell Sources: Animal-derived, immortalized cell lines, human primary cells, and stem cell-derived cells.
  • Technologies: Microfluidics (continuous flow and droplet-based systems), scaffold-based cultures (natural or synthetic), and scaffold-free methods such as bioreactors or hanging drop techniques.
  • Product Types: Instruments for imaging and culturing, plus consumable kits and reagents.
  • End Users: Academic and research institutes, CROs, pharmaceutical and biotechnology companies, and regulatory agencies.
  • Regions: Americas (notably the United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (key markets include the UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and additional countries).
  • Key Companies: Emulate Inc., MIMETAS B.V., CN Bio Innovations Ltd., Hurel Corporation, TissUse GmbH, Epithelix Sàrl, MatTek Life Sciences Inc., InSphero AG, Kirkstall Ltd, and Stemina Biomarker Discovery Inc.

Key Takeaways for Strategic Decision Makers

  • In vitro lung models are transitioning from early proof-of-concept to routine integration across preclinical drug development pipelines, particularly in high-throughput and personalized workflows.
  • Adoption is accelerated by regulatory directives encouraging alternatives to animal testing, with agencies introducing validation frameworks and data standardization requirements to ensure safety and efficacy.
  • Microfluidic technologies and organoid innovations expand the physiological relevance and throughput of lung models, enhancing their utility in screening therapeutic candidates and evaluating chronic exposure scenarios.
  • The choice of cell source—whether animal-derived, human primary, or stem cell-based—impacts model fidelity, reproducibility, scalability, and ethical considerations, now making flexibility a market differentiator.
  • End users across academic, CRO, and regulatory sectors are leveraging these platforms to address a range of objectives, from mechanism discovery to late-stage safety evaluation.
  • Geographic trends reveal strong leadership in North America for clinical translation, proactive regulatory harmonization in Europe and the Middle East, and rapid scale-up of biotechnology strategies in Asia-Pacific markets.

Tariff Impact on Value Chains

The 2025 introduction of new US tariffs affects the supply chain for in vitro lung model platforms. Higher duties on imported microfluidic parts, reagents, and precision hardware create new cost pressures, leading stakeholders to seek domestic suppliers and adjust sourcing strategies. These adjustments impact project timelines and have encouraged collaborative models for resource sharing, as well as strengthened regional partnerships to build more resilient sourcing networks across the Americas, Europe, and Asia.

Methodology & Data Sources

This report draws on a robust methodology combining primary research—such as expert interviews and field surveys—with extensive secondary analysis of peer-reviewed literature, regulatory guidelines, and patent filings. Data triangulation and iterative peer review ensure reliability and strategic relevance for senior decision-makers.

Why This Report Matters

  • Enables C-level executives to make informed investments by mapping the evolving opportunities across application areas, technologies, and geographies.
  • Highlights actionable insights to optimize sourcing, partnering, and regulatory compliance strategies amid ongoing supply chain and tariff challenges.
  • Supports future-ready planning through segmented, unbiased perspectives on the competitive landscape and innovation pipelines.

Conclusion

The in vitro lung model market stands as a focal point for advancing respiratory research and reducing animal testing. As industry, academic, and regulatory partners move toward greater adoption, ongoing innovation, and harmonized standards, these platforms are shaping the next wave of respiratory disease research and drug discovery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. in Vitro Lung Model Market, by Model Type
8.1. Introduction
8.2. 2D Cell Cultures
8.2.1. Cell Line Cultures
8.2.2. Primary Cell Cultures
8.3. 3D Organoids
8.3.1. Alveolar Organoids
8.3.2. Bronchial Organoids
8.4. Lung-On-A-Chip
8.5. Precision-Cut Lung Slices
9. in Vitro Lung Model Market, by Application
9.1. Introduction
9.2. Disease Modeling
9.3. Drug Discovery & Development
9.4. Personalized Medicine
9.5. Toxicity Testing
10. in Vitro Lung Model Market, by Cell Source
10.1. Introduction
10.2. Animal-Derived Cells
10.3. Cell Lines
10.4. Human-Derived Cells
10.4.1. Primary Cells
10.4.2. Stem Cell-Derived Cells
11. in Vitro Lung Model Market, by Technology
11.1. Introduction
11.2. Microfluidics
11.2.1. Continuous Flow Systems
11.2.2. Droplet-Based Systems
11.3. Scaffold-Based Cultures
11.3.1. Natural Scaffolds
11.3.2. Synthetic Scaffolds
11.4. Scaffold-Free Cultures
11.4.1. Bioreactors
11.4.2. Hanging Drop
12. in Vitro Lung Model Market, by Product Type
12.1. Introduction
12.2. Instruments
12.3. Kits & Reagents
13. in Vitro Lung Model Market, by End Users
13.1. Introduction
13.2. Academic & Research Institutes
13.3. CROs
13.4. Pharmaceutical & Biotechnology Companies
13.5. Regulatory Agencies
14. Americas in Vitro Lung Model Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa in Vitro Lung Model Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific in Vitro Lung Model Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Emulate, Inc.
17.3.2. MIMETAS B.V.
17.3.3. CN Bio Innovations Ltd.
17.3.4. Hurel Corporation
17.3.5. TissUse GmbH
17.3.6. Epithelix Sàrl
17.3.7. MatTek Life Sciences, Inc.
17.3.8. InSphero AG
17.3.9. Kirkstall Ltd
17.3.10. Stemina Biomarker Discovery, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. IN VITRO LUNG MODEL MARKET MULTI-CURRENCY
FIGURE 2. IN VITRO LUNG MODEL MARKET MULTI-LANGUAGE
FIGURE 3. IN VITRO LUNG MODEL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IN VITRO LUNG MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINE CULTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELL CULTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ALVEOLAR ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BRONCHIAL ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY LUNG-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRECISION-CUT LUNG SLICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ANIMAL-DERIVED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DROPLET-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY NATURAL SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HANGING DROP, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 78. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 79. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 81. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 82. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 85. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 86. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 159. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 161. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 163. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 164. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 171. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 185. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 186. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 187. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 188. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 190. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 191. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 193. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 194. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 195. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. ITALY IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 197. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 198. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 199. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 200. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 207. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 245. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 246. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 247. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 248. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 254. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 255. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. DENMARK IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 269. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 270. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 271. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 272. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 274. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 275. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 277. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 278. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 279. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. QATAR IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 281. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 282. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 283. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 284. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 286. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 287. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 290. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 291. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. FINLAND IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 318. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 319. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 320. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 322. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 323. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 325. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2030 (USD MILLION)
TABLE 326. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2030 (USD MILLION)
TABLE 327. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. EGYPT IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 329. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 330. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2030 (USD MILLION)
TABLE 331. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2030 (USD MILLION)
TABLE 332. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 334. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2030 (USD MILLION)
TABLE 335. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 336. TURKEY IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2030 (USD MILLION)
TABLE 337. TURKEY IN VITR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this In Vitro Lung Model market report include:
  • Emulate, Inc.
  • MIMETAS B.V.
  • CN Bio Innovations Ltd.
  • Hurel Corporation
  • TissUse GmbH
  • Epithelix Sàrl
  • MatTek Life Sciences, Inc.
  • InSphero AG
  • Kirkstall Ltd
  • Stemina Biomarker Discovery, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 812.58 Million
Forecasted Market Value ( USD ) by 2030 $ 1770 Million
Compound Annual Growth Rate17.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

In Vitro Lung Model - Global Strategic Business Report - Product Image

In Vitro Lung Model - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
In Vitro Lung Model Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

In Vitro Lung Model Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
In-Vitro Lung Model Market Report 2025 - Product Image

In-Vitro Lung Model Market Report 2025

  • Report
  • 200 Pages
  • Global
From
In Vitro Lung Model Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

In Vitro Lung Model Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Lungs in Vitro Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Lungs in Vitro Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 89 Pages
  • Global
From

About the In Vitro Lung Model Market

The In Vitro Lung Model market is a subset of the In Vitro Diagnostics (IVD) industry. It is composed of products and services used to simulate the human lung in a laboratory setting. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. In Vitro Lung Models are typically composed of a combination of cell cultures, organoids, and 3D printed scaffolds. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. The In Vitro Lung Model market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, PromoCell, Lonza, and Corning. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.